Literature DB >> 23761115

Gravimetry in sweating assessment in primary hyperhidrosis and healthy individuals.

Tomasz J Stefaniak1, Monika Proczko.   

Abstract

OBJECTIVE: Though hyperhidrosis is generally considered a subjectively perceived disease, it seems more and more doubtful that merely subjective evaluation is sufficient to qualify the patient to surgery. The aim of this study was to develop further gravimetry as a method of evaluation of sweating intensity and determination of the applicability of it in post-operative follow-up of primary hyperhidrosis (PHH) patients.
METHODS: Total of 1,485 gravimetry assays has been performed in 343 patients treated for hyperhidrosis and in 220 healthy volunteers. In all of the subjects the measurements were taken from four localizations (face, hands, armpits and trunk) and normalized by body surface of the participant. The measurements were taken twice for every participant to obtain test-retest correlations. Mean values and standard deviations (SD) have been evaluated and on that basis reference values were quantified. Thresholds for diagnosis of hyperhidrosis were quantified on the basis of normal distribution theory as healthy population mean +2 SD.
RESULTS: In healthy volunteers, mean value of gravimetrically evaluated intensity of sweating were: facial: 19.15 ± 14.97 mg/min/m(2), palmar: 18.49 ± 14.06 mg/min/m(2), axillary: 42.39 ± 47.08 mg/min/m(2) and plantar: 15.77 ± 16.87 mg/min/m(2). Thresholds for diagnosis of hyperhidrosis were quantified, respectively as: 49, 46, 136 and 50 mg/min/m(2). The overall test-retest correlation was 0.71.
INTERPRETATION: Gravimetry is easy, reproducible and fast method of evaluation of sweating. The reference values are stable and can serve as a qualifying and follow-up tool for evaluation of the patients with PHH in any localization.

Entities:  

Mesh:

Year:  2013        PMID: 23761115      PMCID: PMC3735961          DOI: 10.1007/s10286-013-0201-2

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


Introduction

Though hyperhidrosis is generally considered a subjectively perceived disease, it seems more and more doubtful that merely subjective evaluation is sufficient to qualify the patient to surgery [1]. Vapometry provides valuable and reliable method of assessment, nevertheless, it is not possible to be performed it in multiple localizations (face, hands, armpits, trunk, feet) in more than one patient at the same time [2]. Gravimetry is a simple, cheap and fast method of objective evaluation of sweating, and seems to be very promising [3-5]. The aim of this study was further development of gravimetry as a method of evaluation of sweating intensity and determination of the applicability of it in post-operative follow-up of primary hyperhidrosis (PHH) patients.

Participants and methods

1,045 gravimetry full assays (obtained from five different areas, together 5,225 single measurements) has been performed in 343 patients evaluated for suspicion of PHH, and during the follow-up visits of 229 patients that have been treated with videothoracoscopic R3-4 thoracoscopic sympathotomy by clipping in our institution as described before [6]. Apart from that 440 measurements (every measurement in four areas, together 1,760 single measurements) were obtained from 220 healthy volunteers (medical students). In all of the subjects the measurements were taken from four localizations (face, hands, armpits and trunk). The evaluation was taken twice in 3 months period of the post-sympathectomy follow-up (follow-up patients) and in 1 week (volunteers) to obtain test–retest measurements. The volunteers filled an anonymous questionnaires (marked by numbers to be combined with gravimetric results and retest scores) on their subjective perception of the intensity of their sweating. Median age of the patients was 29 years (16–72), median age of the volunteers was 24 years (21–28). The male:female ratio in the group of patients was 0.48:1, in the group of students—0.37:1. Neither age distribution, nor gender ratio statistically differentiated the groups. The percentage of students claiming that they are characterized by an increased sweating was 3.1 %. None of them considered the sweating a significant problem or searched for surgical help. Gravimetric assay have been performed similarly to the procedure described by Heckmann et al. [3] and Hund et al. [4]. In short, after 15 minutes’ rest in sitting position, the patients were invited into the air-conditioned measure room in standardized temperature (24–25 °C) and humidity 15–17 %. A standard small cotton gauze pad has been weighted on a precise (d = 0.5 mg) weight scale (Radwag, Poland—scale type WPS 110/C/S, Poland). Then the pad was given to the participant who was asked to wipe carefully the area under evaluation. The procedure in each localization lasted 1 min. Then the pad was weighted again and a difference was calculated. To avoid a bias associated with different body area of participants, the difference was standardized by division by body area calculated with the height of the participant (according to Mosteller, body area [m2] = 0.01667 × height [cm]0.5 × mass [kg]0.5) [7]. The stress stimulus was also standardized by the same description of surgical procedure and possible complications. For the control group, the stress stimulus was also standardized. It was a detailed description of very complex procedure of a final exam in surgery, that the participants were about to face. The study protocol was approved by the local ethical committee of the Medical University of Gdansk, Poland.

Results

Mean gravimetric intensity of sweating in PHH patients prior to surgery was 24.49 ± 45.64 mg/min/m2 for facial, 153.37 ± 160.39 mg/min/m2 for palmar, 66.23 ± 56.18 mg/min/m2 for axillary and 31.24 ± 72.97 mg/min/m2 for abdomino-lumbar localizations. After surgery it was 14.48 ± 11.64 mg/min/m2 for facial, 13.77 ± 17.65 mg/min/m2 for palmar, 23.63 ± 24.56 mg/min/m2 for axillary and 28.86 ± 56.05 mg/min/m2 for abdomino-lumbar localizations. In healthy volunteers, mean value of gravimetrically evaluated intensity of sweating was, respectively, 19.15 ± 14.97, 18.49 ± 14.06, 42.39 ± 47.08 and 15.77 ± 16.87 mg/min/m2. The overall test–retest correlation was 0.71. Test–retest values measured in volunteers for different localizations were: facial 0.64, palmar 0.54, axillary 0.84 and abdomino-lumbar 0.70. In follow-up patients it was, respectively, 0.82, 0.81, 0.79 and 0.66 (only follow-up results were included in test–retest evaluation). Mean population values of gravimetry were calculated for four different areas. To obtain threshold for diagnosis of hyperhidrosis, double standard deviation was added to the mean. In normal distribution, it is calculated that 95.5 % of observations is within mean ±2 SD. Considering that only the upper limit of normative value is important for diagnosing hyperhidrosis, it can be calculated that 2.25 % of cases will be within the range higher than mean + 2 SD. This percentage is in accordance with epidemiological data on predominance of PHH in population, which has been reported to reach 2.8 % [1, 8]. The analysis of the questionnaires of the students confirmed that those who reached higher scores in gravimetric assay were also subjectively considering their sweating as increased. Nevertheless, none of them requested surgery. Therefore, the threshold for diagnosis of PHH was calculated. The thresholds for four different areas are presented in Table 1.
Table 1

Reference values of sweating in different localizations evaluated with gravimetry

LocalizationMean raw value in 1-min test (mg/min)Mean value in 1-min test divided by body surface (mg/min/m2)Upper limit of acceptance defined as mean +2 × standard deviation (mg/min/m2)
Facial301949
Palmar291846
Axillary6142136
Abdomino-lumbar271650
Reference values of sweating in different localizations evaluated with gravimetry

Discussion

In this study, for the first time in worldwide literature, we presented reference values for gravimetric evaluation of intensity of sweating in four localizations (face, hands, armpits and abdomino-lumbar area) in PHH patients and in healthy individuals. Adequate and objective evaluation of intensity of sweating plays an essential role in proper qualification to surgery and further, for reliable assessment of the results of intervention. In some anecdotal cases, despite obvious anhidrosis, the patients may still demand further treatment [9], which may arise from psychiatric conditions, such as body dysmorphic syndrome. In those patients, invasive treatment may lead not only to dissatisfaction, but also to severe psychiatric disturbances or even suicide. In most studies presented in the literature, the authors concentrate on relative impact of different forms of treatment on gravimetrically measured sweating [3, 4, 10–19]. Mostly, such measurements were performed in dermatological settings and concerned the results of botox treatment [3, 4, 13–17, 19] or iontophoresis [12]. In those methods of treatment, associated with low level of transient complications or side effects, even less stringent approach to qualification will not cause long-term harm to the patients. Thanks to regular introduction of the quantitative evaluation of sweating prior and after surgery, it is possible to provide the patients with information on their sweating compared to the reference values. Due to that it was possible to confirm that the preoperative values of abdomino-lumbar sweating in the PHH patients are very low. The increase in sweating in this area is very often subjectively experienced by the patients. Nevertheless, in our study the post-op abdomino-lumbar sweat rate remained low and not above the reference value found in our control subjects. Although this is encouraging and will help reduce the perception of some patients of compensatory hyperhidrosis, it would be necessary to test post-op patients for exercise and heat induced abdomino-lumbar sweating before concluding our post-op patients did not have any compensatory hyperhidrosis. In context of sympathectomy and decision to qualify the patient to this radical form of treatment or to reoperation, it seems essential to obtain also reference values.

Conclusion

Gravimetry is easy, reproducible and fast method of evaluation of sweating. The reference values are stable and can serve as a qualifying and follow-up tool for evaluation of the patients with PHH in any localization.
  17 in total

1.  Definition of axillary hyperhidrosis by gravimetric assessment.

Authors:  Martina Hund; Ilka Kinkelin; Markus Naumann; Henning Hamm
Journal:  Arch Dermatol       Date:  2002-04

2.  Gravimetrically controlled efficacy of subcorial curettage: a prospective study for treatment of axillary hyperhidrosis.

Authors:  T M Proebstle; V Schneiders; J Knop
Journal:  Dermatol Surg       Date:  2002-11       Impact factor: 3.398

3.  Efficacy of iontophoresis with glycopyrronium bromide for treatment of primary palmar hyperhidrosis.

Authors:  H Y Chia; A S L Tan; W S Chong; H L Tey
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-08-03       Impact factor: 6.166

Review 4.  Focal hyperhidrosis: diagnosis and management.

Authors:  Aamir Haider; Nowell Solish
Journal:  CMAJ       Date:  2005-01-04       Impact factor: 8.262

Review 5.  The place of botulinum toxin type A in the treatment of focal hyperhidrosis.

Authors:  N Lowe; A Campanati; I Bodokh; S Cliff; P Jaen; O Kreyden; M Naumann; A Offidani; J Vadoud; H Hamm
Journal:  Br J Dermatol       Date:  2004-12       Impact factor: 9.302

6.  Botulinum toxin A for axillary hyperhidrosis (excessive sweating).

Authors:  M Heckmann; A O Ceballos-Baumann; G Plewig
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

7.  Efficacy and safety of botulinum toxin type a in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study.

Authors:  Nicholas J Lowe; Paul S Yamauchi; Gary P Lask; Rickie Patnaik; Shilesh Iyer
Journal:  Dermatol Surg       Date:  2002-09       Impact factor: 3.398

8.  Diffusion and short-term efficacy of botulinum toxin A after the addition of hyaluronidase and its possible application for the treatment of axillary hyperhidrosis.

Authors:  Greg Goodman
Journal:  Dermatol Surg       Date:  2003-05       Impact factor: 3.398

9.  US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey.

Authors:  David R Strutton; Jonathan W Kowalski; Dee Anna Glaser; Paul E Stang
Journal:  J Am Acad Dermatol       Date:  2004-08       Impact factor: 11.527

10.  Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.

Authors:  M Naumann; N J Lowe; C R Kumar; H Hamm
Journal:  Arch Dermatol       Date:  2003-06
View more
  7 in total

1.  [Hyperhidrosis-aetiopathogenesis, diagnosis, clinical symptoms and treatment].

Authors:  J Wohlrab; B Kreft
Journal:  Hautarzt       Date:  2018-10       Impact factor: 0.751

Review 2.  How to diagnose and measure primary hyperhidrosis: a systematic review of the literature.

Authors:  Kristina S Ibler; Gregor B E Jemec; Mattias A S Henning; Linnea Thorlacius
Journal:  Clin Auton Res       Date:  2021-03-27       Impact factor: 4.435

3.  Differences in subjective and objective evaluation of hyperhidrosis. Study among medical students.

Authors:  Łukasz Dobosz; Tomasz Stefaniak; Joanna Halman; Anna Piekarska
Journal:  Postepy Dermatol Alergol       Date:  2019-04-08       Impact factor: 1.837

Review 4.  Hyperhidrosis: disease aetiology, classification and management in the light of modern treatment modalities.

Authors:  Anna Kisielnicka; Aneta Szczerkowska-Dobosz; Dorota Purzycka-Bohdan; Roman J Nowicki
Journal:  Postepy Dermatol Alergol       Date:  2022-05-09       Impact factor: 1.664

Review 5.  Oxybutynin as an alternative treatment for hyperhidrosis.

Authors:  Sergio Delort; Evaldo Marchi; Marcos Antônio Corrêa
Journal:  An Bras Dermatol       Date:  2017 Mar-Apr       Impact factor: 1.896

6.  Hyperhidrosis Prevalence: A Disease Underreported by Patients and Underdiagnosed by Physicians.

Authors:  Surajsingh Wadhawa; Sudha Agrawal; Manoj Chaudhary; Sanjib Sharma
Journal:  Indian Dermatol Online J       Date:  2019-11-01

7.  Chinese expert consensus on the surgical treatment of primary palmar hyperhidrosis (2021 version).

Authors:  Yanguo Liu; Wenhan Weng; Yuanrong Tu; Jun Wang
Journal:  Chin Med J (Engl)       Date:  2022-06-05       Impact factor: 6.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.